ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Weinstein Names Permanent Director Of Columbia Comprehensive Center; Gottsman Heads Institute

February 8, 1985

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989